March 3, 2026

Pulse Biosciences, Inc (PLSE) Stock Analysis: Is a 59% Upside Within Reach?

Pulse Biosciences, Inc (NASDAQ: PLSE), a burgeoning player in the healthcare sector, is making waves in the medical instruments and supplies industry with its innovative bioelectric medicine technologies. Headquartered in..

Progyny, Inc. (PGNY) Stock Analysis: Potential 68% Upside with Strong Buy Ratings in Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY), a healthcare plans company specializing in fertility and family-building benefits, is drawing attention with a notable potential upside of 68.39%, according to current analyst ratings. As..

Vera Therapeutics, Inc. (VERA) Stock Analysis: 94.88% Potential Upside Signals Compelling Opportunity

Vera Therapeutics, Inc. (NASDAQ: VERA), a biotechnology company strategically positioned in the healthcare sector, is catching the eye of investors with a striking potential upside of 94.88%. Despite a modest..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A Biotech Gem with 51% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is gaining traction among investors as a promising player in the biotechnology sector. With a current market cap of $2.9 billion, this precision medicine oncology..

ANI Pharmaceuticals (ANIP) Stock Analysis: A Compelling 47% Upside Potential Awaits Investors

For investors seeking opportunities in the healthcare sector, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling case. With a potential upside of 47.07%, as indicated by analysts’ average target price,..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Unveiling a 29% Upside Potential for Savvy Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is garnering attention with its robust 29.39% potential upside, according to recent analyst ratings. With its headquarters nestled..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 44.65% Potential Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX), a prominent player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 44.65% based on current analyst ratings. This San..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 37.76% Potential Upside

Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices industry, is capturing investor attention with a compelling potential upside of 37.76%. Known for its innovative suite of hospital..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a 38.97% Potential Upside Amid Biotech Challenges

Investors eyeing the healthcare sector may find ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) an intriguing prospect. With a market capitalization of $3.86 billion, ACADIA stands as a significant player in the..

Twist Bioscience Corporation (TWST) Stock Analysis: A Look at the 8.71% Potential Upside in the Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, specifically within the diagnostics and research industry, as it continues to capture the interest of investors with its..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Strong Buy Ratings and a Promising 14.42% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biotechnology firm specializing in peptide-based therapeutics, is capturing investor attention with its dynamic pipeline and robust analyst support. With a market capitalization of $6.01..

Premier, Inc. (PINC) Stock Analysis: Navigating a Stable Yet Cautious Path in Healthcare

Premier, Inc. (NASDAQ: PINC) stands as a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.34 billion, Premier, Inc. operates..

QuidelOrtho Corporation (QDEL) Stock Analysis: Potential Upside of Over 50% Amidst Strategic Positioning in Healthcare

QuidelOrtho Corporation (NASDAQ: QDEL) is a compelling entity within the healthcare sector, focusing on medical devices. With a market capitalization of $1.54 billion, the company specializes in diagnostic testing solutions,..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Anticipating a 40% Upside with Strong Buy Ratings

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector, is garnering attention from investors with its significant 40.35% potential upside, as indicated by current analyst target prices...

SS Innovations International (SSII) Stock Analysis: Unpacking the 192.5% Revenue Growth in the Healthcare Sector

In the dynamic landscape of the healthcare sector, India-based SS Innovations International Inc. (SSII) is making waves with its impressive revenue growth. The company, operating in the medical devices industry,..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 60% Upside Potential Amidst Healthcare Growth

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the medical care facilities industry. With a robust market..

ARS Pharmaceuticals, Inc. (SPRY): Analyst Consensus Sees 214% Upside Potential

Investors eyeing opportunities in the biotechnology sector may want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a promising player focusing on innovative treatments for severe allergic..

Schrodinger, Inc. (SDGR) Stock Analysis: Investors Eye a Potential 93% Upside Amid Market Turbulence

Schrodinger, Inc. (NASDAQ: SDGR) is capturing investor attention with a compelling potential upside of 93.42%, according to recent analyst ratings. As a prominent player in the healthcare sector, specifically within..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 33% Upside Potential in the Medical Device Sector

Artivion, Inc. (AORT), a prominent player in the healthcare sector specializing in medical devices, has been attracting investor attention with its diverse product range and promising market valuation. Headquartered in..

Concentra Group Holdings Parent (CON) Stock Analysis: 20% Upside Potential with Strong Buy Ratings

For investors eyeing opportunities in the healthcare sector, Concentra Group Holdings Parent, Inc. (CON) presents an intriguing proposition. With a market capitalization of $3.04 billion, the company is a significant..

Search

Funds

March 3, 2026

Search

Funds

March 3, 2026

FTSE 100

Funds